Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.

  Pharmaceutical Executive Europe  E-News
 
March 23, 2010

IN THIS ISSUE
NYCOMED GROWTH STRATEGY
ANTI-COUNTERFEITING
CHRONIC FATIGUE SYNDROME




cover
From Midsize to Big Size
Guido Oelkers, Nycomed’s EVP, Commercial Operations, talks exclusively about the company’s plans for ‘exuberant growth’ in the emerging markets. More...
cover
The EU Anticounterfeiting Debate Heats Up
Reflector reports on how various stakeholders with a vested interest are intensifying their arguments. More...
cover
Kill or Cure? Chronic Fatigue Syndrome
A race is on to find the cause and develop an effective treatment for this controversial condition. But is it being run fairly? More...
Also in this week’s issue:
10 New Countries Identified as ‘Pharmerging Markets’
Novartis Scoops Second Malaria Project Award
Run Your Sales Territory Like a Standalone Business
Survey

This week we asked...

In this, the worst recession of recent times, how would you say your company is performing compared with a year ago?


Better 44%
Worse 28%
About the same 28%


You can now follow us on Twitter atTwitter.com/pharmexecdigi

Talk to us:
jupton@advanstar.com

Advertise with us:
jgray@advanstar.com

                           You are subscribed to %%list.name%% as %%emailaddr%%.Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail

at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom